Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma

NCT ID: NCT02947607

Last Updated: 2023-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

799 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-31

Study Completion Date

2019-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is the investigation of new host-microbiome interactions promoting adenoma formation and adenocarcinoma progression. For that purpose, the investigators will collect saliva, stool and colon biopsy specimens from patients referred to colonoscopy or surgical resection of colorectal tumor. Besides, a questionnaire about diet, lifestyle and medical history will be collected. Sample analysis will involve simultaneous characterization of host and microbiota genomic and transcriptomic components.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Adenoma and Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy control

Patients undergoing lower GI endoscopy without any colorectal adenoma or carcinoma.

Colon biopsies

Intervention Type PROCEDURE

Adenoma

Patients undergoing lower GI endoscopy with presence of colorectal adenoma detected.

Colon biopsies

Intervention Type PROCEDURE

Colorectal cancer

Patients diagnosed with colorectal cancer and referred to surgical carcinoma resection.

Colon biopsies

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colon biopsies

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is willing and able to give informed consent for the participation in the study before any protocol-specific screening procedures are performed
* Male or female, aged 18 years or above
* Referred to lower GI endoscopy. Referral reasons can be among others:

* Positive FOBT (Fecal Occult Blood Test)
* Follow up after polypectomy
* Screening because of age
* Bleeding
* Abdominal pain
* Familial or past history of colon cancer or adenoma
* Abnormal imaging such as barium enema
* Change in bowel habits
* Both self-referrals, referrals from external GP or specialists and internal referrals can be included.


* Participant is willing and able to give informed consent for the participation in the study before any protocol-specific screening procedures are performed
* Male or female, aged 18 years or above
* Diagnosis of CRC for which resection is planned
* Both internal and external referrals from specialists can be included

Exclusion Criteria

* Previous diagnosis of an inflammatory bowel disease
* Previous diagnosis of intestinal polyposis syndrome

CRC patients


* Previous diagnosis of an inflammatory bowel disease
* Previous diagnosis of intestinal polyposis syndrome
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

Sponsor Role collaborator

KU Leuven

OTHER

Sponsor Role collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitaire Ziekenhuizen Leuven

Leuven, Flemish Brabant, Belgium

Site Status

Academisch Medisch Centrum

Amsterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

s57084

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.